HS-10365, a highly potent and selective RET tyrosine kinase inhibitor, demonstrates robust activity in RET fusion positive NSCLC patientsShun Lu,Qiming Wang,Lin Wu, Ligang Xing, Yintao Li,Liang Han,Xiaorong Dong,Hongying Wei, Wen Xu,Chuan Li,Liuqing Yang, Qiong WuCANCER RESEARCH(2023)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要